Hypothesis: Different members of the Nogo system are expressed in the mammalian cochlea. Background: The protein Nogo has gained a lot of attention during the last couple of years because it inhibits neurite outgrowth in the adult central nervous system. In contrast to the central nervous system, very little is known regarding the expression and possible function of the Nogo system within the inner ear. Methods: Using reverse-transcriptaseYpolymerase chain reaction and immunohistochemistry, we analyzed for the expression of members of the Nogo system within the cochlea. In addition, we determined hearing levels of Nogo A knockout and wildtype mice with auditory brainstem response audiometry. Results: In this study, we demonstrate the expression of Nogo A, B, C, and of Nogo receptor mRNA in the organ of Corti, spiral ganglion, and stria vascularis. Immunohistochemistry revealed that Nogo A and Nogo receptor localize to the spiral ganglion neurons. Interestingly, Nogo A expression was also observed in the outer and inner hair cells of the organ of Corti. As revealed by light microscopy, deletion of Nogo A does not alter cochlear microanatomy. We have assessed hearing levels in 10-month old wild-type and Nogo A knockout mice, and thereby, we could not detect any differences between these 2 groups. Conclusion: Different members of the Nogo family are expressed in the mammalian cochlea. Deletion of Nogo A does not alter cochlea microanatomy or hearing levels compared with wild-type mice. Key Words: ApoptosisVHair cellsVInner earVNogo A knockout miceVNogoR.
Development of the nervous system is characterized by extensive but highly controlled axon outgrowth. With maturation of the central nervous system, the growth capacity of axons decreases so that, in contrast to the peripheral nervous system, central nervous system axons do not regenerate after injury in the adult animal (1) . Myelin especially impedes axon growth in the adult central nervous system (2, 3) . The discovery and characterization of specific regeneration and growth of inhibitory proteins of the adult central nervous system, in particular, Nogo A (3), which is one of the most potent, was a breakthrough. The 3 Nogo isoforms A, B, and C (4Y6) share a common carboxy-terminal region that indicates their membership to the reticulon family (RTN4) of proteins (7) . The receptor for Nogo A is the glycoprotein Nogo receptor (NgR) (3) . Nogo A is a neurite growth inhibitory protein of 1,163 amino acids (rat sequence; apparent molecular weight, 200 kDa). In contrast to Nogo B and C, which show no or only weak neurite growth inhibitory activity and occur in many tissues (8) , Nogo A is predominantly present in the central nervous system. Although Nogo A mRNA is present in oligodendrocytes (9) , the protein is found in the most inner and outer myelin membranes (8, 10) .
Interestingly, Nogo A appears very late in evolution, at the Bfrog level [ (11) . This could explain the well-known high-regeneration potential of the spinal cord after lesion in fish and salamanders, which lack Nogo A (12) . In fish, amphibians, and birds, regeneration of hair cells is also possible (13, 14) . However, the regeneration of hair cells in the avian auditory epithelium occurs only in response to externally triggered hair cell trauma (15, 16) . Importantly, hair cell regeneration in birds occurs after hair cell and hearing function have matured (17) .
The neurite growth inhibitory activity of Nogo A has been studied both in vitro and in vivo (3). For example, after spinal cord lesion, Nogo A knockout mice and rats or monkeys treated with Nogo A function blocking antibodies showed increased regenerative sprouting and elongation of corticospinal tract fibers, in parallel with enhanced functional recovery. Compensatory growth of spared intact fibers was also improved (3, 18) . Very similar results were obtained with Nogo A blocking soluble NgR fragments, NgR blocking peptides, inhibition of the Rho-A/Rho kinase pathway, or high concentrations of cAMP (3, 19) . Recent results have demonstrated that the adult brain also has a certain capacity for plastic reorganization and self-repair, which can be enhanced by inactivation of the Nogo/NgR system (20, 21) .
Until today, there was limited information in the literature concerning the expression and possible role of Nogo proteins in the cochlea. Furthermore, there is only 1 study reporting expression of RTN4 mRNA in the murine inner ear (22) . Based on a yeast 2-hybrid screen, the authors found that the C-terminus of Nogo interacts with connexin 26 (22) .
In this study, we characterized the expression of the Nogo isoforms and NgR in the cochlea. In addition, we analyzed whether the deletion of Nogo A altered the histoarchitecture of the cochlea, as revealed by temporal bone histology. Finally, we assessed hearing levels in wild-type mice and compare it with the hearing levels of Nogo A knockout mice.
MATERIALS AND METHODS

Animal Procedures
All animal procedures were performed according to protocols approved by the Kantonales Veterinäramt, Zurich, Switzerland. Postnatal Days 2 to 5 Sprague-Dawley (SD) rats (Harlan, Netherlands), postnatal Days 3 to 6, and adult Nogo A knockout mice, as well as wild-type mice (see succeeding sentences) were used throughout the study. For the auditory brainstem response (ABR) audiometry, 10-month-old wild-type mice (C57BL) and Nogo A knockout mice were used. Organ Culture p2-to 5-day-old SD rats were killed, and the cochleae were carefully dissected to separate the organ of Corti (OC) from the spiral ganglion, stria vascularis, and Reissner membrane (23) . The OC explants were maintained in Dulbecco's modified Eagle medium, supplemented with 10% fetal calf serum, 25 mM HEPES, and 30 U/ml penicillin (Invitrogen AG, Switzerland). In all experiments, an 8-hour period was allowed for the explants to recover in culture from the isolation procedure.
Nogo A Knockout Mice
Generation, backcrossing, and characterization of Nogo A knockout mice (pure C57bl/6 background) and the corresponding wildt-ype mice are described (24, 25) .
RNA Extraction
After culturing 5 OC's, ganglions, and stria vascularis from SD rat pups, they were transferred to RNAlater solution (Qiagen AG, Switzerland) for a period of 2 days. RNAlater solution prevents mRNA from being degraded. RNA isolation was then performed using the RNeasy RNA mini kit (Qiagen) using the tissue homogenizer Ultra-Turrax T8 (IKA-Werke) according to supplier's instructions. The quality and quantity of the isolated RNA was determined with a NanoDrop ND 1000 (NanoDrop Technologies, Wilmington DL, USA) and Bioanalyzer 2100 (Agilent, Waldbronn, Germany). Only those samples with a 260-/280-nm ratio between 1.8 and 2.1 and a 28S/18S ratio within 1.5 to 2 were further processed. 
Reverse-TranscriptaseYPolymerase Chain Reaction
Total RNA (1Kg) was reverse-transcribed into doublestranded cDNA with the first strand cDNA synthesis kit for reverse-transcriptaseYpolymerase chain reaction (RT-PCR; Roche, Germany) according to the supplier's instructions. Polymerase chain reaction was performed using the PCR Master Mix (Roche, Germany) with primers specific for Nogo A, B, C, and NgR (Table 1) . A-Actin primers were used as a positive control for the PCR reaction. Polymerase chain reaction reactions were performed under the following conditions: 35 cycles (Nogo C, 40 cycles), each cycle consisting of denaturation at 94-C for 1 minutes, annealing at 50-C for 1 minute, and extension at 72-C for 2 minutes.
The PCR products were sequenced (Microsynth, Switzerland) and visualized under UV light in 2 % agarose gel containing 0.5 Kg/ml ethidium bromide.
Immunohistochemistry
Rats or mice were anesthetized with a 1:1 mixture of Ketasol-100 (Graeub) and 2% Rompun (Bayer AG), 100 mg/kg, given intraperitoneally, 3 minutes before perfusion. Perfusions were performed transcardially with 4% paraformaldehyde in phosphatebuffered saline (PBS), pH 7.2, for 5 min. The temporal bones were removed and postfixed in the same fixative for 24 hours at 4-C. Samples were washed in phosphate buffer, pH 7.2, 4 times for 20 minutes and then dehydrated in a graded series of ethanol (30, 50, 70 , and 100%), each for 15 minutes. Once the samples had been dehydrated, cochleae were dissected in 100% ethanol under a high-power dissecting microscope, embedded in paraffin, and sectioned serially at a thickness of 4 to 7 Km. After sectioning, material was immersed twice in xylene for 10 minutes, followed by 100, 96, 80, and 70% ethanol, each for 5 minutes, for deparaffinization. Endogenous peroxidase activity was blocked by incubating the samples for 10 minutes in 3% H 2 O 2 /methanol. Nonspecific background staining was blocked by incubation for 30 minutes in goat/rabbit serum in 0.15% bovine serum albumin/ PBS and 0.5% TRITON-X, followed by primary antibody incubation for 12 hours at 4-C. Rabbit antiYNogo A (H-300) and goat anti-NgR (N-20) antibodies were used at 1:50 and 1:25 dilutions, respectively. Detection was performed by incubation with biotinylated secondary antibodies, 30 minutes at room temperature, followed by 30-minute incubation with avidin-biotin-HRP complex (ABC kit; Vectastain, Vector Laboratories, Burlingame, CA, USA). Visualization was performed with 3,3-diaminobenzidine tetra hydrochloride tablets (Sigma) following suppliers protocol. In the negative control, the primary antibody was replaced by PBS. Tissue slides of rat brain served as positive control. Slices from the same cochlea were stained with hematoxylin-eosin (HE) and used as controls as well as to study possible differences in the microanatomy between the Nogo A knockout and wild-type mice.
Immunofluorescence
For immunofluorescence studies, OC explants were fixed in 4% paraformaldehyde in PBS (pH 7.2) and permeabilized with 5% Triton X-100 in PBS with 10% fetal bovine serum. To reduce unspecific binding, sections were treated with PBS containing 2% bovine serum albumin for 30 minutes at room temperature. The samples were then incubated with rabbit antiNogo A (H-300) antibody (1:200) overnight at 4-C. After repetitive washing in PBS, the samples were incubated with secondary antiYrabbit fluorescein isothiocyanateYconjugated antibody (1:100) for 2 hours at room temperature. In the negative control, the primary antibody was replaced by PBS. Samples were visualized on a fluorescence microscope (Olympus IX71) and photographed using AxioCam (Zeiss) immediately after staining. All antibodies were purchased from Santa Cruz Biotechnology Inc (Santa Cruz, CA, USA).
ABR Audiometry
For ABR measurements, 4 C57BL wild-type males (10 mo) and 4 Nogo A knockout males (10 mo) were used.
Auditory sensitivity was assessed with ABR thresholds that were obtained with TDT System 3 auditory evoked potential workstation running BioSigRP software (Tucker-Davis Technologies, Alachua, FL, USA). Mice were anesthetized with an intraperitoneal injection of a mixture of ketamine and xylazine (0.12/0.01 mg/g body weight). Auditory brainstem response thresholds were recorded with subcutaneous stainless-steel electrodes as the potential difference between an electrode on the vertex and an electrode on the mastoid, whereas the lower back served as ground. Auditory brainstem response waveforms were recorded with a TDT RA4LI low-impedance digital headstage and a RA4PA Medusa preamp controlled by an RA16 digital signal processor (Tucker-Davis Technologies). Click stimulus (0.1-ms duration, 10/s rate) were reduced in intensity from 80 dB sound pressure level (SPL) in 5-dB steps. Auditory brainstem response waveforms were averaged in response to 500 clicks. Tone pips (5-ms duration, 20/s rate) at frequencies of 3, 6, 12, 16, 24, 32 , and 48 kHz were reduced in intensity from 80 dB SPL in 5-dB steps. The response waveforms were averaged in response to 300 tone bursts at each tested frequency/amplitude combination. The stimuli were delivered through a closed acoustic system and were calibrated using a sound level meter (precision integrating sound level meter type 2218; Brüel & Kjaer, Naerum, Denmark) and a 2CC coupler. The hearing threshold was defined as the lowest intensity that induced the appearance of a visually detectable first peak.
RESULTS
Nogo A, B, C, and NgR mRNA Are Expressed in the Mammalian Cochlea We detected Nogo A, B, C, and NgR mRNA in the OC, ganglion, and stria vascularis (Fig. 1AYC ) from rat pups by RT-PCR. RNA from the rat brain served as positive control. In the negative control, reactions were included with no RT enzyme. The transcripts were subsequently sequenced, and the correct sequences were verified. Figure 1D shows the OC with the Reissner membrane still attached but with the spiral ganglion completely removed.
Nogo A and NgR Protein Are Expressed in the Mammalian Cochlea Immunohistochemistry was performed to localize Nogo A and NgR in the cochlea. Tissue sections of the cochlea were stained with Nogo A antibody (H-300) and NgR antibody (N-20; Figs. 2 and 3) . Nogo A immunoreactivity was found in the spiral ganglion (Fig. 2B ) and in the OC (Fig. 2D) . No staining was found in the negative Fig. 2A, C) . Nogo receptor immunoreactivity was found in the spiral ganglion (Fig. 3B) . No staining was found in the negative control (Fig. 3A) .
controls (
Nogo A Knockout Mice and Wild-Type Mice Show
Similar Cochlear Microanatomy Slices from the temporal bones of Nogo A knockout and wild-type mice were stained with HE to study possible differences in the microanatomy.
As revealed by microscopy, there were no significant differences in the microanatomy between the Nogo A knockout and the wild-type mice (Fig. 4) . Both display an OC with 3 rows of outer hair cells and 1 row of inner hair cells (Fig. 4C, D) . The morphology of the tectorial and basilar membranes, the spiral ganglion neurites, and the stria vascularis seems to be similar (Fig. 4AYF) .
Nogo A Localizes to the Hair Cell Membrane Fluorescence microscopy was performed to localize Nogo-A in the OC. Organ of Corti explants were stained with Nogo A antibody and visualized with a fluorescein isothiocyanateYconjugated secondary antibody. Nogo A could be localized in the hair cell membrane (Fig. 5B) . No staining was found in the negative control (Fig. 5A) .
Nogo A Knockout Mice and Wild-Type Mice Show the Same Degree of Hearing Loss There was no significant difference in click-induced ABR thresholds between C57BL and Nogo A knockout mice (C57BL, 35 dB SPL; and Nogo A knockout mice, 32.5 dB SPL; Fig. 6A ). An example of click-induced ABR thresholds of a Nogo A knockout mouse is given in Figure 6B .
In addition, tone pipYinduced ABR thresholds did not differ between C57BL and Nogo A knockout mice. Thresholds for 3 kHz averaged 73.3 dB SPL for both groups. For 6 kHz, thresholds were 71.7 dB SPL for C57BL and 70 dB SPL for Nogo A knockout mice. For 12 kHz, thresholds were 60 dB SPL for C57BL and 57.5 dB SPL for Nogo A knockout mice. At higher frequencies, ABR thresholds could not be detected in most of the animals in both groups (data not shown).
DISCUSSION
In the present study, we showed that Nogo A and its isoforms, as well as NgR, are expressed in the cochlea, specifically in the OC, the spiral ganglion, and the stria vascularis. Immunfluorescence microscopy revealed a membrane-bound localization of Nogo A. Moreover, we demonstrated that deletion of Nogo A does not detectably alter cochlear microanatomy. Using brainstem response audiometry, we assessed hearing levels in 10-month-old wild-type and Nogo A knockout mice. Therefore, we could not detect any differences between Nogo A knockout and wild-type mice.
Until recently, there was no information available concerning the expression and potential role of Nogo and its isoforms in the inner ear. Recently, 1 study (22) described on the basis of a yeast 2-hybrid screen that Nogo might physically interact with connexin 26 in the inner ear. Connexin 26 is a component of the gap junctions and is encoded by the GJB2 gene. Numerous studies have shown that GJB2 mutations account for a significant proportion of recessive genetic deafness (26, 27) . It was speculated that Nogo may take part in the trafficking of connexin 26 in the inner ear. In our study, we demonstrated that Nogo and its isoforms are expressed in the inner ear. Using histochemistry with an antibody directed against Nogo A, we detected a strong staining of spiral ganglion neurites for Nogo A. This is not so surprising because it has been shown that Nogo A is found in the innermost and outermost myelin membranes in the central nervous system (8, 10) , and it has been demonstrated that myelin sheaths can be found in the spiral ganglion and cochlear nerve (28) .
Studies in the central nervous system demonstrated that oligodendrocyte Nogo A is a major contributor to the negative effect on neurite outgrowth and may play a role in maintaining synaptic connections in the healthy central nervous system (29, 30) . It is very likely that Nogo A has similar function within the spiral ganglion: to influence outgrowth of spiral ganglion neurites and to maintain synaptic connections within the inner ear such as between spiral ganglion neurites and hair cells. However, it is well known that neurite outgrowth is possible in the mammalian cochlea after damage to the OC (31Y33). Therefore, it is not likely that Nogo A inhibits neurite outgrowth in the mammalian cochlea because the cochlea in these studies presumably expressed Nogo A. The functions of Nogo might be relevant for future clinical applications such as manipulation of spiral ganglion neurites to grow toward the electrodes of a cochlear implant or toward newly differentiated hair cells after stem cell transplantation.
We found expression of both Nogo A mRNA and protein within the OC. The significance of this finding has yet to be elucidated. Recent studies have demonstrated that Nogo A is also expressed in a subset of central neurons where it localizes not only to cell bodies but also to axons (8, 10) . What might be the role of the expression of Nogo A in the OC? Today, we can only speculate regarding a possible role of this protein in the OC. Theoretically, it might be possible that Nogo A has a function in maintaining a nonregenerative state of hair cells within the OC. However, we do not have data to support this hypothesis. Future studies are needed to explore the function of Nogo A in the cochlea.
Nogo A does not seem to play an important role in the development of the auditory part of the inner ear because we could not detect any differences in the temporal bone microanatomy and hearing levels between Nogo A knockout mice and wild-type mice.
In contrast to Nogo A, the physiologic roles of the more widely expressed Nogo B and C are yet to be established. Suggested functions for these proteins include endoplasmatic reticulum structure (34) or a role in membrane trafficking (35) .
We conclude that the different Nogo isoforms are expressed within the inner ear. Nogo A genetic deletion does not alter the microanatomy of the cochlea, and finally, Nogo A deletion does not alter hearing levels in old Nogo A knockout mice compared with wild-type mice. Subsequent studies will need to investigate more closely the function of the Nogo isoforms in the inner ear.
